MedTrace Logo

Effectiveness, Acceptability and Feasibility of a Communication and Care Coordinator (CCC) Model in Facilitating Serious Illness Communication (SIC) and Care in Patients With Cancer

NCT07733973 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 560

Last updated 2026-07-29

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the communication and care coordinator (CCC) model in a national cancer institute and assess the utility of the model in facilitating serious illness communication (SIC) and care for patients with cancer.

The study aims are:

* To assess the effectiveness of the CCC model in improving patient outcomes.
* To assess the effectiveness of the CCC model in increasing rates of SIC and advance care planning (ACP) record documentation.
* To assess the acceptability of the CCC model to patients and clinicians.
* To evaluate the feasibility of implementing a CCC model in oncology care.

Researchers will compare results from the CCC intervention arm and usual care arm, to see if the CCC model can help improve patient outcomes and facilitate SIC between patients and clinicians.

Patient participants will:

* Follow the assignment of their clinician, who will be assigned randomly to either the usual care group or the intervention group.
* Be assigned a CCC and receive 6 CCC sessions over the course of 3 months (if assigned to CCC intervention arm).
* Complete 3 study assessment visits at baseline, Week 6, and 3 months
* Be invited to a one-time interview to share their study experience (optional, if selected and if in CCC intervention arm).

Conditions

Interventions

OTHER

CCC Intervention

CCC sessions will be on exploring participant's illness journey thus far, their concerns, values and priorities.

Sponsors & Collaborators

  • National Cancer Centre, Singapore

    lead OTHER

Principal Investigators

  • Shirlyn NEO Hui Shan, MD, PhD · National Cancer Centre, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2028-06-30
Completion
2029-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07733973 on ClinicalTrials.gov